Remove 2018 Remove Government Remove IT Remove Provider
article thumbnail

An Additional Physician from Leading Sarasota Cardiology Practice to Now Offer the Hybrid Choice™ Concierge Program from Concierge Choice Physicians

Concierge Choice Physicians

The physician continues to accept insurance and government programs, as before. They receive enhanced support and service from staff members, and medical advocacy and coordination with other health providers the patient may see. Caruso is now one of nine physicians at Heart Specialists of Sarasota to offer CCP’s Hybrid Choice.

article thumbnail

‘Gas Station Heroin’ Spurs Spike in Poison Control Calls, FDA Warns

Physician's Weekly

Tianeptine is sold in a number of countries as a government-approved treatment for depression. The FDA sent a warning letter to the maker of a product called Tianna in 2018. It claimed to provide “an unparalleled solution to cravings for opiates.” Between 2018 and 2023, tianeptine-related calls to U.S.

Medical 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Green Practice News: April 2025

My Green Doctor

from 2000 to 2018 among people over 65 years old. The Power of Healthcare Professionals as Trusted Messengers Patients Trust Their Healthcare Providers A recent study found that 64% of physicians recognize environmental sustainability affects their patients’ health, yet only 17% feel comfortable discussing it ( PubMed ).

article thumbnail

The Most Engaging Decision You’ll Read All Year – Five Stars

FDA Law Blog

Koblitz — You know a court decision is going to be worth reading when the judges compare FDA’s regulatory governance of flavored e-cigarettes to a Shakespearean gaslighting. Clissold & Sara W. FDA originally set the PMTA deadline as August 8, 2022, but a district court in Maryland ordered FDA to shorten it.

article thumbnail

FDA Publishes Discussion Paper Seeking Feedback on 3D Printing of Medical Devices at the Point of Care

FDA Law Blog

In May 2016, FDA released a draft guidance document titled “Technical Considerations for Additive Manufactured Devices” (see our blog post on the draft guidance here ), which was finalized in 2018 (see our blog post on the final guidance here ). This guidance document is still in effect today. products intended for medical purposes).

Medical 98
article thumbnail

Supreme Court Finds CMS’ Reduction of Medicare Hospital Outpatient Payment Rates for 340B Hospitals was Not Authorized by Statute

FDA Law Blog

Kirschenbaum — In 2017, the Centers for Medicare & Medicaid Services (“CMS”) issued a final rule to significantly decrease the rate the government will reimburse 340B hospitals in 2018 for outpatient prescription drugs from average sales price (“ASP”) plus 6% to ASP minus 22.5%. By Faraz Siddiqui & Alan M. 52494 (Nov.

article thumbnail

FDA Publishes Discussion Paper Seeking Feedback on 3D Printing of Medical Devices at the Point of Care

FDA Law Blog

In May 2016, FDA released a draft guidance document titled “Technical Considerations for Additive Manufactured Devices” (see our blog post on the draft guidance here ), which was finalized in 2018 (see our blog post on the final guidance here ). This guidance document is still in effect today. products intended for medical purposes).

Medical 75